BPC-157/TB-500 5/5MG

BPC-157/TB-500 5/5MG

$53.00

BPC-157 / TB-500 5mg/5mg is a research-grade peptide blend supplied in lyophilized form. It is intended for laboratory studies on angiogenesis, actin-binding pathways, and tissue-support mechanisms.

Title	# Purchased	Discount
Bulk Discount	10 - 15	5% $50.35
Bulk Discount	16 - 20	10% $47.70
Bulk Discount	21 - 25	15% $45.05
Bulk Discount	26 - 100	20% $42.40

Purchase & earn 53 points!

Description

BPC-157 / TB-500 5mg/5mg

BPC-157 is a small protein made to copy a natural protein found in the stomach.

Thymosin beta-4, a natural protein made by the body. It has been studied for its part in helping cells grow, repair, and move.

Research applications include:

Laboratory studies of angiogenesis and blood vessel development
Investigations into actin-binding and cell migration processes
Models examining synergistic peptide interactions in tissue repair
Controlled research into stress adaptation and peptide-based signaling pathways

The manufacturer produces this peptide blend under strict quality control standards and supplies it as a high-purity, research-grade formulation, ensuring consistency and reliability across scientific studies.

For laboratory research use only. Not intended for human or veterinary use. This product is not approved to diagnose, treat, cure, or prevent any condition. Store in a cool, dry place and handle according to appropriate lab safety protocols.

Research Use Only – Legal Disclaimer

All products on this site are for research and development use only. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Nura Peptide is a chemical supplier. Nura Peptide is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Nura Peptide is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.